- Home
- REED vs INM Comparison
REED vs INM Comparison
Compare REED & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REED | INM |
|---|---|---|
| Founded | 1987 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 7.7M |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | REED | INM |
|---|---|---|
| Price | $0.82 | $1.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.7K | ★ 104.4K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,065,000.00 | $4,942,633.00 |
| Revenue This Year | $18.74 | N/A |
| Revenue Next Year | $18.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.73 | $0.58 |
| 52 Week High | $5.97 | $2.50 |
Technical Indicators
Market Signals| Indicator | REED | INM |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | N/A |
| Support Level | $0.76 | N/A |
| Resistance Level | $1.42 | N/A |
| Average True Range (ATR) | 0.11 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 69.59 | 0.00 |
Price Performance
Historical ComparisonAbout REED Reed's Inc.
Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.